In silico regenerative medicine: how computational tools allow regulatory and financial challenges to be addressed in a volatile market.

Geris, L; Guyot, Y; Schrooten, J; Papantoniou, I

Geris, L; Guyot, Y; Schrooten, J; Papantoniou, I.

Afiliação

Geris L; Prometheus, Division of Skeletal Tissue Engineering, KU Leuven, Onderwijs en Navorsing 1 (+8), Herestraat 49-PB813, Leuven 3000, Belgium; Biomechanics Research Unit, Université de Liège, Chemin des Chevreuils 1 - BAT 52/3, Liège 4000, Belgium; Department of Mechanical Engineering, Biomechanics Secti
Guyot Y; Prometheus, Division of Skeletal Tissue Engineering, KU Leuven, Onderwijs en Navorsing 1 (+8), Herestraat 49-PB813, Leuven 3000, Belgium; Biomechanics Research Unit, Université de Liège, Chemin des Chevreuils 1 - BAT 52/3, Liège 4000, Belgium.
Schrooten J; Antleron BVBA , Leuven , Belgium.
Papantoniou I; Prometheus, Division of Skeletal Tissue Engineering, KU Leuven, Onderwijs en Navorsing 1 (+8), Herestraat 49-PB813, Leuven 3000, Belgium; Skeletal Biology and Engineering Research Center, KU Leuven, Onderwijs en Navorsing 1 (+8), Herestraat 49-PB813, Leuven 3000, Belgium.

Interface Focus ; 6(2): 20150105, 2016 Apr 06.

Article em En | MEDLINE | ID: mdl-27051516

Palavras-chave

bioprocess; bioreactor; in silico model; regenerative medicine; tissue engineering

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Health_economic_evaluation Idioma: En Revista: Interface Focus Ano de publicação: 2016 Tipo de documento: Article País de publicação: Reino Unido

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google